<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[license agreement and pfizer inc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/license+agreement+and+pfizer+inc..html?i=11]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to license agreement and pfizer inc.]]></description>
	<s:counts start="0" returned="5" found="5" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Helsinn and Pfizer Laboratories (Pty) Ltd Sign a License Agreement for the Marketing of Aloxi(R) in South Africa.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200603/ai_n23524956]]></link>
		<description><![CDATA[LUGANO, Switzerland and JOHANNESBURG, South Africa, March 10  /PRNewswire/ --     Helsinn Healthcare SA, and Pfizer Laboratories Pty  Ltd, announce the signing of an agreement granting Pfizer in South  Africa, the exclusive license and distribution ri  LUGANO, Switzerland and JOHANNESBURG, South Africa, March...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 10 Mar 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Incyte to Host Conference Call Today to Discuss Collaborative Research and License Agreement with Pfizer for the Development and Commercialization of CCR2 Antagonists; Conference Call is Scheduled to Begin at 8:30 a.m. ET Today]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Nov_21/ai_n15862200]]></link>
		<description><![CDATA[WILMINGTON, Del. -- Incyte Corporation (Nasdaq:INCY) announced that it will host a conference call at 8:30 am ET today to discuss its collaborative research and license agreement with Pfizer for the development and commercialization of CCR2 antagonists. A copy of the press release, also released today, can be accessed at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 21 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer and Incyte Enter Collaborative Research and License Agreement for the Development and Commercialization of CCR2 Antagonists]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Nov_21/ai_n15862217]]></link>
		<description><![CDATA[NEW YORK & WILMINGTON, Del. -- Incyte Corporation (NASDAQ:INCY):]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 21 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer Inc. (Active Pharmaceutical Ingredient Watch).(seeks to terminate license agreement with Novo Nordisk )(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200306/ai_n13212184]]></link>
		<description><![CDATA[NOVO NORDISK A/S reports that Pfizer Inc. has attempted to  terminate the license agreement under which Pfizer markets Novo  Nordisk's portfolio of hormone replacement therapy products,  Activella and Vagifem, in the US. In 2002, Novo Nordisk gained a    NOVO NORDISK A/S reports that Pfizer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 09 Jun 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Inhale Therapeutic Systems and Pfizer Inc Enter Into Pulmonary Insulin Product Development and License Agreement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1995_Jan_19/ai_16114551]]></link>
		<description><![CDATA[PALO ALTO, Calif.--HealthWire--Jan. 19, 1995--Inhale Therapeutic Systems (Nasdaq:INHL) announced today that it has signed an agreement with Pfizer Inc (NYSE:PFE) to collaborate on the development of insulin products using Inhale's non-invasive pulmonary drug delivery system for macromolecules.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 19 Jan 1995 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
</channel>
</rss>
